Brandon Capital Partners

Quick Fit Check

Investment focus

Sectors

From firm website, not verified

Investment Stages

From firm website, not verified

Geographic Focus

Australia
New Zealand

Investment thesis

Australia's leading life sciences and healthcare VC with A$700M+ AUM. Manages the Medical Research Commercialisation Fund (MRCF) and has invested in 50+ companies translating research breakthroughs into clinical-stage therapeutics.

Typical check size

€1M – €10M

How To Pitch Brandon Capital Partners

No Stated Policy
Brandon Capital Partners hasn't published an outreach policy. A short, specific cold email is the safest default.
Source

Portfolio highlights

Firebrick Pharma - Australian pharmaceutical company developing nasal spray treatments
Polynovo - Australian biotech developing tissue regeneration products (ASX IPO)
Adherium - Digital health company for respiratory medication adherence (ASX/NASDAQ)

Website reachable as of Aug 2026. Focus and check size as listed by the firm, not independently verified.

Ready To Reach Brandon Capital Partners?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.

Research with AI

Learn more about Brandon Capital Partners using AI:

Ask ChatGPTAsk Perplexity